Unum Therapeutics Inc (NASDAQ:UMRX)

0.31
Delayed Data
As of 3:59pm ET
 -0.045 / -12.68%
Today’s Change
0.30
Today|||52-Week Range
4.62
-56.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues1.7M2.0M3.8M3.1M
 
 
 
 
 
Depreciation And Amortization325.0K330.0K352.0K330.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.8M12.3M12.5M14.6M
 
 
 
 
 
Research And Development9.1M10.3M10.8M12.4M
 
 
 
 
 
Total Operating Expenses11.1M12.6M12.8M14.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.4M-10.6M-9.0M-11.8M
 
 
 
 
 
Other Expenses157.0K3.0K-10.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.0M-10.2M-8.6M-11.7M
 
 
 
 
 
Net Income-9.0M-10.2M-8.6M-11.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS29.2M29.9M30.1M30.1M
 
 
 
 
 
Shares To Calculate EPS Diluted29.2M29.9M30.1M30.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.34-$0.29-$0.39
 
 
 
 
 
EPS Diluted-$0.31-$0.34-$0.29-$0.39